SLC5A2 and Ascites: (’sodium glucose cotransporter 2 inhibitor’/exp OR ’sglt2 inhibitor’ OR empagliflozin OR dapagliflozin OR canagliflozin OR ertugliflozin) AND ('ascites’/exp OR ascites OR ’fluid retention’ OR ’refractory ascites’) AND ('liver cirrhosis’/exp OR cirrhosis OR ’hepatic cirrhosis’)